Square Pharmaceuticals PLC. (DSE:SQURPHARMA)

DSE:SQURPHARMA Balance Sheet

Financials in millions BDT. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	50,521	52,013	50,094	48,962	43,364	32,564
Cash & Short-Term Investments	50,521	52,013	50,094	48,962	43,364	32,564
Cash Growth	4.38%	3.83%	2.31%	12.91%	33.16%	20.59%
Accounts Receivable	4,794	2,551	3,421	2,159	1,636	1,520
Other Receivables	3,101	1,952	2,702	1,236	1,280	1,276
Receivables	7,895	4,503	6,122	3,395	2,916	7,681
Inventory	13,851	12,582	12,227	8,214	7,245	5,687
Prepaid Expenses	70.01	101.51	81.62	57.56	46.17	44.98
Other Current Assets	1,900	2,005	1,962	1,718	1,505	1,407
Total Current Assets	74,238	71,206	70,487	62,348	55,076	47,384
Property, Plant & Equipment	30,817	27,750	26,059	27,183	22,884	20,874
Long-Term Investments	36,601	33,682	25,270	22,227	17,492	13,561
Other Intangible Assets	-	0.05	0.11	-	-	-
Total Assets	141,655	132,637	121,816	111,758	95,452	81,819
Accounts Payable	1,261	1,455	1,002	625.98	666.17	553.79
Accrued Expenses	1,444	1,476	1,327	1,257	1,121	988.27
Current Portion of Long-Term Debt	622.24	614.54	618.61	200	-	-
Current Income Taxes Payable	1,637	912.27	356.1	911.5	572.68	978.04
Other Current Liabilities	1,163	823.65	926.1	666.85	818.87	721.46
Total Current Liabilities	6,127	5,282	4,229	3,662	3,179	3,242
Long-Term Debt	355.56	814.54	1,368	1,714	103.71	-
Long-Term Deferred Tax Liabilities	481.74	619.08	1,022	1,179	1,275	1,213
Total Liabilities	6,964	6,716	6,620	6,555	4,557	4,454
Common Stock	8,865	8,865	8,865	8,865	8,865	8,442
Additional Paid-In Capital	2,035	2,035	2,035	2,035	2,035	2,035
Retained Earnings	124,191	115,196	103,578	93,463	78,855	67,298
Comprehensive Income & Other	-405.22	-177.13	717.6	839.61	1,139	-410.88
Total Common Equity	134,686	125,919	115,196	105,203	90,895	77,365
Minority Interest	4.78	2.32	0.71	0.47	0.5	-
Shareholders' Equity	134,691	125,922	115,197	105,203	90,895	77,365
Total Liabilities & Equity	141,655	132,637	121,816	111,758	95,452	81,819
Total Debt	977.79	1,429	1,987	1,914	103.71	-
Net Cash (Debt)	59,070	59,877	52,697	51,395	47,885	35,256
Net Cash Growth	5.16%	13.62%	2.53%	7.33%	35.82%	17.45%
Net Cash Per Share	66.64	67.55	59.45	57.98	54.02	39.77
Filing Date Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Total Common Shares Outstanding	886.45	886.45	886.45	886.45	886.45	886.45
Working Capital	68,111	65,924	66,258	58,686	51,898	44,143
Book Value Per Share	151.94	142.05	129.95	118.68	102.54	87.27
Tangible Book Value	134,686	125,919	115,196	105,203	90,895	77,365
Tangible Book Value Per Share	151.94	142.05	129.95	118.68	102.54	87.27
Land	-	8,486	6,632	6,446	6,136	5,711
Buildings	-	11,897	11,716	10,317	9,756	9,744
Machinery	-	30,103	29,322	26,788	25,510	24,061
Construction In Progress	6,321	1,774	1,083	6,388	2,460	724.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.